STOCKHOLDERS’ EQUITY |
12 Months Ended |
|---|---|
Dec. 31, 2025 | |
| Equity [Abstract] | |
| STOCKHOLDERS’ EQUITY | NOTE 3. STOCKHOLDERS’ EQUITY
The total number of authorized shares of our common stock, par value $ per share, was shares. As of December 31, 2025 and 2024, there were and common shares issued and outstanding, respectively.
The total number of authorized shares of our preferred stock, par value $ per share, was . There was preferred stock outstanding as of December 31, 2025 and 2024.
During the year ended December 31, 2024 the Company sold unregistered shares of its Common Stock to eight private accredited investors for an aggregate of $576,000 ($ - $ per share)
The Company issued unregistered shares of its Common Stock valued at $79,209 during the year ended December 31, 2024 as payment for services provided to the Company.
The Company issued of restricted securities awards valued at $120,000 ($ per share) during January 2024 and recorded $ as stock compensation expense in the quarter ended March 31, 2024 as payment for services provided by two employees of the Company. Services were cancelled as of December 2024 and restricted common shares were cancelled.
The Company issued of restricted securities awards valued at $192,000 ($ per share) on July 1, 2024 and recorded $ as stock compensation expense in the year ended December 31, 2024 as payment for services provided by the consultant of the Company. The remaining will vest quarterly through April 2026.
During the year ended December 31, 2025 the Company sold unregistered shares of its Common Stock to four private accredited investors for an aggregate of $390,000 ($ per share)
During the year ended December 31, 2025 the Company issued unregistered shares of its Common Stock for services valued at $167,611.
|